Dr. Scott Fisher, MD
InvestorPsychiatric Lead at Iter Investments
Find your path to Dr. Scott Fisher, MD
15 people in our graph share verified history with Dr. Scott Fisher, MD — schools, employers, funds. One of them is your warm intro.
Andrew HallunlockedDr. Scott Fisher, MD: together at Iter Investments
×11Dr. Scott Fisher, MD: together at Iter Investments
About
Psychiatrist with certification in psychedelic therapy and research. Leads FDA Phase 2 clinical trial assessing psilocybin efficacy for severe depression.
Colleagues at Iter Investments
Amanda Barton
Legal Advisor at Iter Investments
Andrew Hall
Venture Partner at Iter Investments
Andrew Hall, PhD
Scientific Lead at Iter Investments
David Wood, Esq. PhD
Intellectual Property Lead at Iter Investments
Dr. Michelle Weiner, DO MPH
Clinical Lead at Iter Investments
Dustin Robinson
Managing Director at Iter Investments
Dustin Robinson, Esq. CPA
Founder at Iter Investments
Edgar Asebey, Esq
FDA Lead at Iter Investments
Frequently asked questions
- Who is Dr. Scott Fisher, MD?
- Psychiatrist with certification in psychedelic therapy and research. Leads FDA Phase 2 clinical trial assessing psilocybin efficacy for severe depression.
- Where does Dr. Scott Fisher, MD work?
- Dr. Scott Fisher, MD is Psychiatric Lead at Iter Investments.







